US Stock MarketDetailed Quotes

ELDN Eledon Pharmaceuticals

Watchlist
  • 4.360
  • +0.140+3.32%
Close Dec 20 16:00 ET
  • 4.360
  • 0.0000.00%
Post 16:02 ET
260.46MMarket Cap-1.85P/E (TTM)

Eledon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
83.16%20.51M
40.06%14.5M
-2.17%10.87M
8.09%43M
2.97%10.34M
5.66%11.2M
11.54%10.35M
12.69%11.11M
7.90%39.78M
6.98%10.04M
Selling and administrative expenses
22.13%3.99M
39.42%4.4M
15.42%3.46M
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
-3.29%12.7M
-12.89%2.79M
-General and administrative expense
22.13%3.99M
39.42%4.4M
15.42%3.46M
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
-3.29%12.7M
-12.89%2.79M
Research and development costs
108.30%16.52M
40.34%10.11M
-8.67%7.41M
11.94%30.31M
-2.52%7.07M
6.43%7.93M
25.39%7.2M
22.28%8.11M
14.09%27.08M
17.28%7.25M
Operating profit
-83.16%-20.51M
-40.06%-14.5M
2.17%-10.87M
-8.09%-43M
-2.97%-10.34M
-5.66%-11.2M
-11.54%-10.35M
-12.69%-11.11M
-7.90%-39.78M
-6.98%-10.04M
Net non-operating interest income expense
Other net income (expense)
7,444.97%97.48M
45.12%-30.41M
-3,875.74%-12.76M
-52.61%-73.54M
59.12%-19.76M
917.32%1.29M
-154,005.56%-55.41M
6,860.00%338K
-688,471.43%-48.19M
-48.34M
Gain on sale of security
21,669.53%96.44M
44.33%-31.27M
---13.34M
---76.21M
---20.47M
--443K
---56.18M
----
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
---48.65M
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--48.65M
----
Other non- operating income (expenses)
22.73%1.04M
12.13%869K
69.82%574K
478.79%2.67M
134.21%712K
568.50%849K
2,052.78%775K
6,860.00%338K
6,500.00%462K
--304K
Income before tax
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
-138.65%-87.97M
-522.10%-58.38M
Income tax
Net income
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
Net income continuous Operations
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
Minority interest income
Net income attributable to the parent company
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
Preferred stock dividends
Other preferred stock dividends
22.54M
0
Net income attributable to common stockholders
649.45%54.43M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
Basic earnings per share
418.18%1.05
61.31%-1.06
-5.33%-0.79
23.21%-4.73
77.02%-0.94
54.79%-0.33
-321.54%-2.74
-8.70%-0.75
-164.38%-6.16
-581.67%-4.09
Diluted earnings per share
3.03%-0.32
61.31%-1.06
-5.33%-0.79
23.21%-4.73
77.02%-0.94
54.79%-0.33
-321.54%-2.74
-8.70%-0.75
-164.38%-6.16
-581.67%-4.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense 83.16%20.51M 40.06%14.5M -2.17%10.87M 8.09%43M 2.97%10.34M 5.66%11.2M 11.54%10.35M 12.69%11.11M 7.90%39.78M 6.98%10.04M
Selling and administrative expenses 22.13%3.99M 39.42%4.4M 15.42%3.46M -0.09%12.69M 17.24%3.27M 3.85%3.27M -10.93%3.15M -7.04%3M -3.29%12.7M -12.89%2.79M
-General and administrative expense 22.13%3.99M 39.42%4.4M 15.42%3.46M -0.09%12.69M 17.24%3.27M 3.85%3.27M -10.93%3.15M -7.04%3M -3.29%12.7M -12.89%2.79M
Research and development costs 108.30%16.52M 40.34%10.11M -8.67%7.41M 11.94%30.31M -2.52%7.07M 6.43%7.93M 25.39%7.2M 22.28%8.11M 14.09%27.08M 17.28%7.25M
Operating profit -83.16%-20.51M -40.06%-14.5M 2.17%-10.87M -8.09%-43M -2.97%-10.34M -5.66%-11.2M -11.54%-10.35M -12.69%-11.11M -7.90%-39.78M -6.98%-10.04M
Net non-operating interest income expense
Other net income (expense) 7,444.97%97.48M 45.12%-30.41M -3,875.74%-12.76M -52.61%-73.54M 59.12%-19.76M 917.32%1.29M -154,005.56%-55.41M 6,860.00%338K -688,471.43%-48.19M -48.34M
Gain on sale of security 21,669.53%96.44M 44.33%-31.27M ---13.34M ---76.21M ---20.47M --443K ---56.18M ---- ---- ----
Special income (charges) ---- ---- ---- --0 ---- ---- ---- ---- ---48.65M ----
-Less:Impairment of capital assets ---- ---- ---- --0 ---- ---- ---- ---- --48.65M ----
Other non- operating income (expenses) 22.73%1.04M 12.13%869K 69.82%574K 478.79%2.67M 134.21%712K 568.50%849K 2,052.78%775K 6,860.00%338K 6,500.00%462K --304K
Income before tax 877.01%76.97M 31.71%-44.91M -119.37%-23.63M -32.48%-116.54M 48.45%-30.1M 5.40%-9.91M -611.15%-65.76M -9.21%-10.77M -138.65%-87.97M -522.10%-58.38M
Income tax
Net income 877.01%76.97M 31.71%-44.91M -119.37%-23.63M -32.48%-116.54M 48.45%-30.1M 5.40%-9.91M -611.15%-65.76M -9.21%-10.77M -154.93%-87.97M -563.00%-58.38M
Net income continuous Operations 877.01%76.97M 31.71%-44.91M -119.37%-23.63M -32.48%-116.54M 48.45%-30.1M 5.40%-9.91M -611.15%-65.76M -9.21%-10.77M -154.93%-87.97M -563.00%-58.38M
Minority interest income
Net income attributable to the parent company 877.01%76.97M 31.71%-44.91M -119.37%-23.63M -32.48%-116.54M 48.45%-30.1M 5.40%-9.91M -611.15%-65.76M -9.21%-10.77M -154.93%-87.97M -563.00%-58.38M
Preferred stock dividends
Other preferred stock dividends 22.54M 0
Net income attributable to common stockholders 649.45%54.43M 31.71%-44.91M -119.37%-23.63M -32.48%-116.54M 48.45%-30.1M 5.40%-9.91M -611.15%-65.76M -9.21%-10.77M -154.93%-87.97M -563.00%-58.38M
Basic earnings per share 418.18%1.05 61.31%-1.06 -5.33%-0.79 23.21%-4.73 77.02%-0.94 54.79%-0.33 -321.54%-2.74 -8.70%-0.75 -164.38%-6.16 -581.67%-4.09
Diluted earnings per share 3.03%-0.32 61.31%-1.06 -5.33%-0.79 23.21%-4.73 77.02%-0.94 54.79%-0.33 -321.54%-2.74 -8.70%-0.75 -164.38%-6.16 -581.67%-4.09
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion with Explanatory Notes -- -- -- -- Unqualified Opinion with Explanatory Notes --
Heat List
US
Overall
Symbol
Price
% Chg

No Data